Ruah Alyamany: Evaluating Safety of TPO-RA Use in ITP After Splenectomy
Ruah Alyamany, Advanced Classical (Benign) Hematology Fellow at Mayo Clinic, shared a post on LinkedIn:
“Excited to share our latest study in ITP.
In clinical practice, esp. in classical (benign) hematology, safety and risk can be easily assumed rather than examined. In ITP, many patients receive TPO-RAs after splenectomy without full consideration of potential consequences. Here we take a closer look, evaluating their general safety in this setting and with a closer look at thrombosis.”
Read the full article here.
Title: Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Authors: Ruah Alyamany, Damon E Houghton, Meera Sridharan, Rajiv K Pruthi, Surbhi Shah, Richard C. Godby, Alexandra P Wolanskyj-Spinner, Ronald S. Go
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Dec 6, 2025, 18:02ASH25 Day 1: Don’t Miss The Highlights
-
Dec 6, 2025, 15:44Atul Gupta on Where The Healthcare Innovation is Headed
-
Dec 6, 2025, 15:22Nathan White on How Inflammation Contributes to Coagulopathy After Trauma
-
Dec 6, 2025, 15:02Anas Younes on AstraZeneca’s Aims in Blood Cancer to Be Presented at ASH25
-
Dec 6, 2025, 14:08David Alderman: ASH25 is Live
-
Dec 6, 2025, 13:53Isabelle Mahé Presents The Proposals from INNOVTE CAT Working Group
-
Dec 6, 2025, 11:50Steve Tuplin on Roche’s Mission at ASH25
-
Dec 6, 2025, 11:13Khaled Musallam on The Lancet Haematology Podcast: Your ASH25 Roadmap
-
Dec 6, 2025, 06:34Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California